Press Releases Moderna, Inc.

Equities

MRNA

US60770K1079

Delayed Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
116 ^USD	-0.96%		-5.31%	+16.59%

Jul. 02	Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling	MT
Jul. 02	Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine	Jul. 02	AQ
US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine	Jul. 02	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jul. 02	PR
Moderna, Inc.	Jun. 28	AQ
Impacting Human Health: Reflecting on Moderna’s Third Annual ESG Report	Jun. 25	PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 24	PR
Moderna : Marking CMV Awareness Month in June	Jun. 24	PU
Squamous Cell Carcinoma Pipeline 2024 \| FDA Approvals, Clinical Trials, Therapies, MOA, ROA \| Hookipa Pharma, Zenith Epigenetics, HiFiBiO, Nanobiotix, GSK, AstraZeneca, VCN Biosciences, Moderna	Jun. 19	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 15	PR
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer	Jun. 13	AQ
FDA Approves Moderna's MRESVIA Vaccine	Jun. 10	AQ
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	Jun. 10	BU
Moderna : The Potential Impact of Combination Vaccines on Public Health	Jun. 10	PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 07	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA	Jun. 07	PR
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	Jun. 05	AQ
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	Jun. 03	BU
Moderna : ASCO 2024 (Adjuvant melanoma)	Jun. 03	PU
Moderna : ASCO 2024 Trial in Progress (melanoma)	Jun. 03	PU
Moderna : ASCO 2024 Trial in Progress (NSCLC)	Jun. 03	PU